Literature DB >> 18388149

Developmental dependence on NurRE and EboxNeuro for expression of pituitary proopiomelanocortin.

Pierre-Luc Lavoie1, Lionel Budry, Aurélio Balsalobre, Jacques Drouin.   

Abstract

Cell-specific expression of the pituitary proopiomelanocortin (POMC) gene depends on the combinatorial action of a large number of DNA-binding transcription factors (TFs). These include general and cell-restricted factors, as well as factors that act as effectors of signaling pathways. We have previously defined in the distal POMC promoter a composite regulatory element that contains targets for basic helix-loop-helix TFs conferring cell specificity and for NGFI-B orphan nuclear receptors that are responsive to CRH signaling and to glucocorticoid negative feedback. These factors act on neighboring regulatory elements, the Ebox(Neuro) and NurRE, respectively. Currently, the Ebox(Neuro) is thought to be the target of NeuroD1 during fetal development, but this factor may not account for activity in the adult pituitary; it is also unknown whether the NurRE and NGFI-B-related factors are active before establishment of the hypothalamic-pituitary portal system. In order to assess the importance of these regulatory elements and their cognate TFs throughout pituitary organogenesis and in the adult, we have assessed the activity of mutant POMC promoters in transgenic mice throughout development. These experiments indicate that the Ebox(Neuro) and cognate basic helix-loop-helix factors are required throughout development and in the adult gland, beyond expression of NeuroD1. Similarly, the data reveal sustained importance of the NurRE and its cognate factors throughout pituitary development. These data contrast the sustained dependence throughout development on the same regulatory elements with the highly dynamic patterns of TF expression and the modulation of their activity in response to signaling pathways.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18388149      PMCID: PMC5419434          DOI: 10.1210/me.2007-0567

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  31 in total

1.  NeuroD1/beta2 contributes to cell-specific transcription of the proopiomelanocortin gene.

Authors:  G Poulin; B Turgeon; J Drouin
Journal:  Mol Cell Biol       Date:  1997-11       Impact factor: 4.272

2.  Antagonism between Nur77 and glucocorticoid receptor for control of transcription.

Authors:  A Philips; M Maira; A Mullick; M Chamberland; S Lesage; P Hugo; J Drouin
Journal:  Mol Cell Biol       Date:  1997-10       Impact factor: 4.272

3.  Protein-protein interactions and transcriptional antagonism between the subfamily of NGFI-B/Nur77 orphan nuclear receptors and glucocorticoid receptor.

Authors:  Christine Martens; Steve Bilodeau; Mario Maira; Yves Gauthier; Jacques Drouin
Journal:  Mol Endocrinol       Date:  2004-12-09

4.  Ptx1 regulates SF-1 activity by an interaction that mimics the role of the ligand-binding domain.

Authors:  J J Tremblay; A Marcil; Y Gauthier; J Drouin
Journal:  EMBO J       Date:  1999-06-15       Impact factor: 11.598

5.  Rb enhances p160/SRC coactivator-dependent activity of nuclear receptors and hormone responsiveness.

Authors:  Eric Batsché; Julien Desroches; Steve Bilodeau; Yves Gauthier; Jacques Drouin
Journal:  J Biol Chem       Date:  2005-03-14       Impact factor: 5.157

6.  Heterodimerization between members of the Nur subfamily of orphan nuclear receptors as a novel mechanism for gene activation.

Authors:  M Maira; C Martens; A Philips; J Drouin
Journal:  Mol Cell Biol       Date:  1999-11       Impact factor: 4.272

7.  Pituitary homeobox 1 (Ptx1) is differentially expressed during pituitary development.

Authors:  C Lanctôt; Y Gauthier; J Drouin
Journal:  Endocrinology       Date:  1999-03       Impact factor: 4.736

8.  The T-box factor Tpit recruits SRC/p160 co-activators and mediates hormone action.

Authors:  Mario Maira; Catherine Couture; Gwendal Le Martelot; Anne-Marie Pulichino; Steve Bilodeau; Jacques Drouin
Journal:  J Biol Chem       Date:  2003-09-11       Impact factor: 5.157

9.  Dimer-specific potentiation of NGFI-B (Nur77) transcriptional activity by the protein kinase A pathway and AF-1-dependent coactivator recruitment.

Authors:  Mario Maira; Christine Martens; Eric Batsché; Yves Gauthier; Jacques Drouin
Journal:  Mol Cell Biol       Date:  2003-02       Impact factor: 4.272

10.  Human and mouse TPIT gene mutations cause early onset pituitary ACTH deficiency.

Authors:  Anne-Marie Pulichino; Sophie Vallette-Kasic; Catherine Couture; Yves Gauthier; Thierry Brue; Michel David; Georges Malpuech; Cheri Deal; Guy Van Vliet; Monique De Vroede; Felix G Riepe; Carl-Joachim Partsch; Wolfgang G Sippell; Merih Berberoglu; Begüm Atasay; Jacques Drouin
Journal:  Genes Dev       Date:  2003-03-15       Impact factor: 11.361

View more
  15 in total

1.  Adult pituitary cell maintenance: lineage-specific contribution of self-duplication.

Authors:  David Langlais; Catherine Couture; Marie Kmita; Jacques Drouin
Journal:  Mol Endocrinol       Date:  2013-06-10

Review 2.  Pituitary gland development and disease: from stem cell to hormone production.

Authors:  Shannon W Davis; Buffy S Ellsworth; María Inés Peréz Millan; Peter Gergics; Vanessa Schade; Nastaran Foyouzi; Michelle L Brinkmeier; Amanda H Mortensen; Sally A Camper
Journal:  Curr Top Dev Biol       Date:  2013       Impact factor: 4.897

3.  Related pituitary cell lineages develop into interdigitated 3D cell networks.

Authors:  Lionel Budry; Chrystel Lafont; Taoufik El Yandouzi; Norbert Chauvet; Geneviève Conéjero; Jacques Drouin; Patrice Mollard
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-11       Impact factor: 11.205

Review 4.  Molecular mechanisms of pituitary organogenesis: In search of novel regulatory genes.

Authors:  S W Davis; F Castinetti; L R Carvalho; B S Ellsworth; M A Potok; R H Lyons; M L Brinkmeier; L T Raetzman; P Carninci; A H Mortensen; Y Hayashizaki; I J P Arnhold; B B Mendonça; T Brue; S A Camper
Journal:  Mol Cell Endocrinol       Date:  2009-12-16       Impact factor: 4.102

Review 5.  Subclinical hyperfunctioning pituitary adenomas: the silent tumors.

Authors:  Odelia Cooper; Shlomo Melmed
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2012-05-22       Impact factor: 4.690

6.  A pituitary-specific enhancer of the POMC gene with preferential activity in corticotrope cells.

Authors:  David Langlais; Catherine Couture; Guillaume Sylvain-Drolet; Jacques Drouin
Journal:  Mol Endocrinol       Date:  2010-12-30

7.  The Ets factor Etv1 interacts with Tpit protein for pituitary pro-opiomelanocortin (POMC) gene transcription.

Authors:  Lionel Budry; Catherine Couture; Aurélio Balsalobre; Jacques Drouin
Journal:  J Biol Chem       Date:  2011-05-26       Impact factor: 5.157

Review 8.  Silent corticotroph adenomas.

Authors:  Odelia Cooper
Journal:  Pituitary       Date:  2015-04       Impact factor: 4.107

9.  The selector gene Pax7 dictates alternate pituitary cell fates through its pioneer action on chromatin remodeling.

Authors:  Lionel Budry; Aurélio Balsalobre; Yves Gauthier; Konstantin Khetchoumian; Aurore L'honoré; Sophie Vallette; Thierry Brue; Dominique Figarella-Branger; Björn Meij; Jacques Drouin
Journal:  Genes Dev       Date:  2012-10-15       Impact factor: 11.361

10.  Single-Cell RNA Sequencing Reveals Novel Markers of Male Pituitary Stem Cells and Hormone-Producing Cell Types.

Authors:  Leonard Y M Cheung; Akima S George; Stacey R McGee; Alexandre Z Daly; Michelle L Brinkmeier; Buffy S Ellsworth; Sally A Camper
Journal:  Endocrinology       Date:  2018-12-01       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.